Skip to main content
. Author manuscript; available in PMC: 2020 Feb 8.
Published in final edited form as: J Adolesc Health. 2019 Aug 5;65(5):651–659. doi: 10.1016/j.jadohealth.2019.05.025

Figure 3.

Figure 3.

(A) WHO clinical stage III/IV event-free survival and (B) WHO advanced/severe immunologic event-free survivala during monotherapy or treatment interruption. aOnly patients who commenced monotherapy or a treatment interruption with a CD4 count >350 cell/μL included in analysis. WHO = World Health Organization.